Findings

What do systematic reviews say?

Refine by population, intervention, comparison or outcome
More filters
Evidence found and GRADE certainty

18 questions · 19 findings · 3 reviews · Acute Respiratory Infections

No studies found 4 · 21.1%GRADE not reported 0 · 0%Very low 3 · 15.8%Low 5 · 26.3%Moderate 7 · 36.8%High 0 · 0%

Epinephrine vs placebo

Admissions at enrollment or < 24 hours (outpatients only) · patients with acute viral bronchiolitis

Epinephrine probably leads to lower admissions at enrollment or < 24 hours (outpatients only) compared with placebo (moderate certainty).

1 finding from 1 review

Epinephrine vs steroids

Admissions overall up to 7 days (outpatients only) · patients with acute viral bronchiolitis

Epinephrine showed no clear difference in admissions overall up to 7 days (outpatients only) compared with steroid (moderate certainty).

1 finding from 1 review

Epinephrine vs placebo

Admissions overall up to 7 days (outpatients only) · patients with acute viral bronchiolitis

Epinephrine showed no clear difference in admissions overall up to 7 days (outpatients only) compared with placebo (low certainty).

1 finding from 1 review

Epinephrine vs salbutamol/albuterol

Admissions at enrollment or < 24 hours (outpatients only) · patients with acute viral bronchiolitis

Epinephrine showed no clear difference in admissions at enrollment or < 24 hours (outpatients only) compared with salbutamol/albuterol (moderate certainty).

1 finding from 1 review

Epinephrine vs salbutamol/albuterol

Admissions overall up to 7 days (outpatients only) · patients with acute viral bronchiolitis

Epinephrine showed no clear difference in admissions overall up to 7 days (outpatients only) compared with salbutamol/albuterol (moderate certainty).

1 finding from 1 review

Epinephrine vs steroids

Admissions (outpatients) · patients with acute viral bronchiolitis

Epinephrine showed no clear difference in admissions (outpatients only) compared with steroid (moderate certainty).

1 finding from 1 review

Epinephrine and steroid vs placebo

Admissions at enrollment or < 24 hours (outpatients only) · patients with acute viral bronchiolitis

Epinephrine and steroid showed no clear difference in admissions at enrollment or < 24 hours (outpatients only) compared with placebo (low certainty).

1 finding from 1 review

Epinephrine and steroid vs placebo

Admissions overall up to 7 days (outpatients only) · patients with acute viral bronchiolitis

Epinephrine and steroid may leads to lower admissions overall up to 7 days (outpatients only) compared with placebo (low certainty).

1 finding from 1 review

Magnesium sulphate + epinephrine vs no treatment or normal saline + epinephrine

Length of hospital stay · children up to 12 months old with acute bronchiolitis

It is very uncertain whether magnesium sulphate + epinephrine changes duration of hospital stay compared with no treatment or normal saline + epinephrine (very low certainty).

1 finding from 1 review

Magnesium sulphate + epinephrine vs no treatment or normal saline + epinephrine

Clinical severity score (CSS) (RDAI score; range 0 to 17; higher = poorer outcomes) measured at 0 to 24 hoursafter treatment · children up to 12 months old with acute bronchiolitis

It is very uncertain whether magnesium sulphate + epinephrine changes clinical severity score (CSS) (RDAI score; range 0 to 17; higher =… compared with no treatment or normal saline + epinephrine (very low certainty).

1 finding from 1 review

Magnesium sulphate + epinephrine vs no treatment or normal saline + epinephrine

Clinical severity score (CSS) (RDAI score; range 0 to 17; higher = poorer outcomes) measured 25 to 48 hoursafter treatment · children up to 12 months old with acute bronchiolitis

It is very uncertain whether magnesium sulphate + epinephrine changes clinical severity score (CSS) (RDAI score; range 0 to 17; higher =… compared with no treatment or normal saline + epinephrine (very low certainty).

1 finding from 1 review